Lenhard et al. BMC Cancer 2012, 12:2 http://www.biomedcentral.com/1471-2407/12/2 32. Rutanen EM, Seppala M: The hCG-beta subunit radioimmunoassay in nontrophoblastic gynecologic tumors. Cancer 1978, 41(2):692-696. 33. Samaan NA, Smith JP, Rutledge FN, Schultz PN: The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma. Am J Obstet Gynecol 1976, 126(2):186-189. 34. Carter PG, Iles RK, Neven P, Ind TE, Shepherd JH, Chard T: The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix. Gynecol Oncol 1994, 55(2):271-276. 35. Grossmann M, Hoermann R, Gocze PM, Ott M, Berger P, Mann K: Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies. Eur J Clin Invest 1995, 25(11):867-873. 36. Guo X, Liu G, Schauer IG, Yang G, Mercado-Uribe I, Yang F, Zhang S, He Y, Liu J: Overexpression of the beta subunit of human chorionic gonadotropin promotes the transformation of human ovarian epithelial cells and ovarian tumorigenesis. Am J Pathol 2011, 179(3):1385-1393. 37. Wurzel RS, Yamase HT, Nieh PT: Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract. J Urol 1987, 137(3):502-504. 38. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, Lang U, Preissner KT: Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002, 87(11):5290-5296. 39. Iles RK, Persad R, Trivedi M, Sharma KB, Dickinson A, Smith P, Chard T: Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer. Br J Urol 1996, 77(1):61-69. 40. Huang CF, Liu DY, Shen K: Follicle stimulating hormone inhibits cisplatin induced apoptosis in ovarian cancer cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003, 25(4):447-450. 41. Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E: Rao Ch V: Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J Clin Endocrinol Metab 2004, 89(2):952-956. 42. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL: The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 1990, 70(2):421-430. 43. Tao YX, Lei ZM, Rao CV: The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands. Life Sci 1997, 60(15):1297-1303. 44. Zhang M, Shi H, Segaloff DL, Van Voorhis BJ: Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod 2001, 64(1):179-187. 45. Lin PC, Li X, Lei ZM: Rao Ch V: Human cervix contains functional luteinizing hormone/human chorionic gonadotropin receptors. J Clin Endocrinol Metab 2003, 88(7):3409-3414. 46. Leuschner C, Enright FM, Gawronska B, Hansel W: Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo. Breast Cancer Res Treat 2003, 78(1):17-27. 47. Rahman NA, Rao CV: Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research. Mol Hum Reprod 2009, 15(1):703-711. 48. Bodek G, Rahman NA, Zaleska M, Soliymani R, Lankinen H, Hansel W, Huhtaniemi I, Ziecik AJ: A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. Breast Cancer Res Treat 2003, 79(1):1-10. 49. Bodek G, Vierre S, Rivero-Muller A, Huhtaniemi I, Ziecik AJ, Rahman NA: A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice. Neoplasia 2005, 7(5):497-508. 50. Gawronska B, Leuschner C, Enright FM, Hansel W: Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gynecol Oncol 2002, 85(1):45-52. 51. Gebauer G, Mueller N, Fehm T, Berkholz A, Beck EP, Jaeger W, Licht P: Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity. Am J Obstet Gynecol 2004, 190(6):1621-1628, discussion 1628. Page 8 of 8 52. Gebauer G, Fehm T, Beck EP, Berkholz A, Licht P, Jager W: Cytotoxic effect of conjugates of doxorubicin and human chorionic gonadotropin (hCG) in breast cancer cells. Breast Cancer Res Treat 2003, 77(2):125-131. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/12/2/prepub doi:10.1186/1471-2407-12-2 Cite this article as: Lenhard et al.: Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC Cancer 2012 12:2. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit